Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15787-15796
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15787
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15787
Table 1 Clinical characteristics of the cohort according to the Montreal classification n (%)
| Characteristics | CD (n = 141) | UC (n = 79) |
| Females | 74 (52) | 39 (49) |
| Age (yr, mean ± SD) | 38.5 ± 12.8 | 47.0 ± 16.1 |
| Disease duration (yr, mean ± SD) | 9.8 ± 6.4 | 10.5 ± 7.2 |
| Location | L1: 63 (45) | E1: 8 (10) |
| L2: 29 (21) | E2: 39 (49) | |
| L3: 44 (31) | E3: 33 (41) | |
| L4: 4 (3) | ||
| Behavior | ||
| B1 | 56 (40) | |
| B2 | 37 (27) | |
| B3 | 46 (33) | |
| IBD surgery | 46 (33) | 2 (3) |
| VD supplementation | 30 (21) | 18 (23) |
- Citation: Hlavaty T, Krajcovicova A, Koller T, Toth J, Nevidanska M, Huorka M, Payer J. Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases. World J Gastroenterol 2014; 20(42): 15787-15796
- URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15787.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15787